Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Sep 13, 2018

30786_dirs_2018-09-13_6a43c963-796f-44b6-a258-ebfee49e3b37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-11

Reporting Person: TSINGOS CHRISTINE A (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-11 Bio-Rad A Common Stock M 660 Acquired 8323.0979 Direct
2018-09-11 Bio-Rad A Common Stock F 229 $308.37 Disposed 8094.0979 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-11 Restricted Stock Units $0 M 160 Disposed Bio-Rad A Common Stock (160) Direct
2018-09-11 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F4: The restricted stock units vest in five equal annual installments beginning September 11, 2016.